Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-Cell Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06717347
What this trial is testing

Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Merck Sharp & Dohme LLC 1,046
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02983617
What this trial is testing

Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adults With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Gilead Sciences 36
Early research (Phase 1)WithdrawnNCT00968461
What this trial is testing

Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders

Who this might be right for
LeukemiaLymphoproliferative Disorders
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00689169
What this trial is testing

Targeted Intensification With ZBEAM and Autologous Stem Cell Transplantation in Patients With High-grade B-Cell Lymphoma

Who this might be right for
Lymphoma, Large Cell, Diffuse
Lymphoma Study Association 75
Not applicableLooking for participantsNCT05366569
What this trial is testing

Bio-CAR-T BS Study

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)Acute Lymphoblastic Leukemia (ALL)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 45
Testing effectiveness (Phase 2)Looking for participantsNCT06834529
What this trial is testing

CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma

Who this might be right for
Relapsed or Refractory B Cell Leukemia and Lymphoma
Affiliated Hospital to Academy of Military Medical Sciences 20
Early research (Phase 1)WithdrawnNCT06003179
What this trial is testing

Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT00285103
What this trial is testing

SPC2996 in Chronic Lymphocytic Leukaemia

Who this might be right for
Chronic Lymphocytic Leukemia
Santaris Pharma A/S 46
Large-scale testing (Phase 3)Study completedNCT03406156
What this trial is testing

A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
AbbVie 120
Early research (Phase 1)UnknownNCT04381741
What this trial is testing

CD19 CAR-T Expressing IL7 and CCL19 Combined With PD1 mAb for Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 24
Not applicableNo Longer AvailableNCT04705454
What this trial is testing

Loncastixumab Tesirine (ADCT-402) Expanded Access Program (EAP) for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
ADC Therapeutics S.A.
Testing effectiveness (Phase 2)Ended earlyNCT02258529
What this trial is testing

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Who this might be right for
Follicular LymphomaSmall Lymphocytic Lymphoma
Gilead Sciences 10
Not applicableNot Yet RecruitingNCT07759661
What this trial is testing

Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Splenic Marginal Zone LymphomaHairy Cell Leukemia (HCL)
IRCCS San Raffaele 64
Not applicableEnded earlyNCT00965861
What this trial is testing

SCRI Tissue Testing Registry

Who this might be right for
MelanomaMyelodysplastic SyndromeMultiple Myeloma+1 more
SCRI Development Innovations, LLC 20
Early research (Phase 1)Ended earlyNCT02706405
What this trial is testing

JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Diffuse Large B-Cell LymphomaRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma+3 more
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00299494
What this trial is testing

Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
B-Cell Lymphoma
Pfizer 119
Early research (Phase 1)Ended earlyNCT05618366
What this trial is testing

Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B Cell LymphomaFollicular Lymphoma
Weill Medical College of Cornell University 3
Large-scale testing (Phase 3)Looking for participantsNCT04332822
What this trial is testing

A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

Who this might be right for
DLBCLDiffuse Large B Cell Lymphoma
Nordic Lymphoma Group 300
Testing effectiveness (Phase 2)Study completedNCT00834951
What this trial is testing

Adjuvant Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma

Who this might be right for
Non Hodgkin's Lymphoma
University of Aarhus 40
Next Page